<DOC>
	<DOC>NCT02499718</DOC>
	<brief_summary>Assessment of the effect and safety of noninvasive positive pressure ventilation for severe stable chronic obstructive pulmonary disease</brief_summary>
	<brief_title>Non-invasive Positive Pressure (NPPV ) for Severe Stable Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Hypercapnia</mesh_term>
	<criteria>clinically stable, hypercapnic GOLD stage IV COPD, aged 18 years or older, baseline arterial carbon dioxide pressure (PaCO2) of 6.7 kPa (50 mmHg) or higher and a pH higher than 7·35, measured after at least 1 h rest in a sitting position. thorax or the lung other than COPD No smoking or Cigarette≤10/day obesity with a bodymass index (BMI) ≥40 kg/m² malignant comorbidities,severe heart failure (New York Heart Association stage IV),unstable angina, and severe arrhythmias.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Non-invasive positive pressure ventilation</keyword>
	<keyword>quality of life</keyword>
	<keyword>long-term oxygen therapy</keyword>
</DOC>